| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | +0.0% |
| R&D Expense | $42.7M | -22.9% |
| SG&A Expense | $19.8M | -1.3% |
| Operating Income | -$62.6M | +16.1% |
| Interest Expense | $3.0M | +489.6% |
| Income Tax | $0 | — |
| Net Income | -$64.8M | +13.4% |
| EPS (Basic) | -$0.96 | +13.5% |
| EPS (Diluted) | -$0.96 | +13.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.2M | -47.0% |
| Current Assets | $64.0M | -44.2% |
| Total Assets | $66.7M | -42.0% |
| Current Liabilities | $6.3M | +10.6% |
| Long-term Debt | $24.9M | +66.0% |
| Total Liabilities | $28.4M | +40.8% |
| Stockholders' Equity | $38.3M | -59.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.7M | +5.9% |
| Investing Cash Flow | $121K | +0.0% |
| Financing Cash Flow | $9.7M | -65.6% |